Sensory Medical Inc. recently announced that it has received commercial clearance for the Relaxis Pad from the U.S. Food and Drug Administration. The medical device uses vibratory counterstimulation to improve the quality of sleep in patients with primary restless legs syndrome (RLS). The Relaxis Pad is available by prescription only.
FDA clears the Relaxis Pad for treatment of restless legs syndrome
2014-06-13T00:00:00-05:00June 13th, 2014|Professional Development|
May 27th, 2022 | 0 Comments
March 7th, 2022 | 0 Comments
November 5th, 2021 | 0 Comments